Antibody Drug Conjugates (ADC) Market Growing at a CAGR 21.82% During 2017 - 2022

News provided by

ReportsnReports

24 Mar, 2017, 16:00 GMT

PUNE, India, March 24, 2017 /PRNewswire/ --

A ReportsnReports.com report says, over the recent years, global antibody drug conjugates market has been growing rapidly as the global sales of Adcetris and Kadcyla have been witnessing rapid growth after their approval. Globally, the growth in the antibody drug conjugates market is driven by large number of ADC drugs in pipeline, rise in global incidences of cancer and wider therapeutic window offered by ADCs.

Browse 3 Tables and 94 Figures, 10 Major Company Profiles, spread across 154 pages available at http://www.reportsnreports.com/reports/927058-global-antibody-drug-conjugates-adc-market-analysis-by-drugs-adcetris-kadcyla-pipeline-drugs-regulations-opportunities-and-forecasts-2017-2022-by-region-n-america-europe-apac-row-by-country-u-th-africa.html.

Companies analyzed in the report are Hoffmann-La Roche Ltd, Seattle Genetics, Takeda, ImmunoGen Inc, Pfizer Inc., Sanofi, AbbVie Inc, Cellldex Therapeutics, Synthon and Progenics Pharmaceuticals

According to research report, "Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022)", global market is projected to display a robust growth represented by a CAGR of 21.82% during 2017 - 2022, chiefly driven by large number of ADC drugs in pipeline, rising number of cancer patients and wider therapeutic window offered by antibody drug conjugates.

Among the drugs, Kadcyla currently dominates the antibody drug conjugates market but will be surpassed by Adcetris in forecasted period. Among the regions, North America is predicted to advance at the highest rate, mainly driven by increase in several ADC molecules expected to gain FDA approval in next few years.

Order a Copy of Report at http://www.reportsnreports.com/purchase.aspx?name=927058.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status, ADC Pipeline - By Cytotoxic Payload, Linker and Target

Regional Markets - N. America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market, Adcetris Market, Kadcyla Market, ADC Pipeline - By Developer, Phase, Indication and Status, ADC Pipeline - By Cytotoxic Payload, Linker and Target

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022): Antibody Drug Conjugates Market (ADC) Market

Global Antibody Drug Conjugates (ADC) Market - Analysis By Drugs (Adcetris, Kadcyla), Pipeline Drugs, Regulations: Opportunities and Forecasts (2017-2022) Report Other Highlights:

  • Market Dynamics - Trends, Drivers, Challenges
  • Porter's Five Forces Analysis
  • SWOT Analysis
  • Policy and Regulation

Related Reports: 

Explore More Reports on Pharmaceuticals at http://www.reportsnreports.com/market-research/pharmaceuticals/.

About Us: 

ReportsnReports.com is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, ReportsnReports.com offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.


Contact:
Ritesh Tiwari
2nd Floor, Metropole Building,
Next to Inox Theatre,
Bund Garden Road, Pune - 411013.
Maharashtra, India.
+ 1 888 391 5441
sales@reportsandreports.com

Connect with Us:

LinkedIn: http://www.linkedin.com/company/reportsnreports

RSS/Feeds:  http://www.reportsnreports.com/feed/l-latestreports.xml